Although I recently suggested that Wall Street has already amply rewarded Procter & Gamble (NYSE:PG) for its self-improvement potential, the company showed in its fiscal second quarter results that it may still have more on the table. While incrementally less momentum in developing economies could eventually develop into another problem to address, P&G management is simultaneously delivering on product innovation/introduction and cost cutting.

SEE: A Guide To Investing In Consumer Staples

Good Results from the Top on Down
P&G posted a good, solid beat for its fiscal second quarter. Revenue rose 2% as reported, but increased 3% on an organic basis (about 1% higher than expected), with even progress in both volume and price. Good results in developed markets are counterbalancing slowing growth in developing markets.

Growth was relatively consistent across product lines, even if the make-up of that growth was not. Grooming saw 2% organic growth (on zero volume growth), while beauty and fabric/home care were both up 3% (on zero and 2% volume growth, respectively). Health care was up 4% (on 3% volume growth), while baby/family care revenue rose 5% on 6% growth in volume.

Cost-cutting and margin improvement are key to the P&G story now, and management continues to deliver good results. Core gross margin improved more than a point, while core/adjusted operating income rose 7% (with no incremental operating margin improvement net of the gross margin improvement). Here, too, the categories were across the board - beauty, fabric/home and baby/family all posted low-to-mid teens segment profit growth, while grooming was flat and health care was down in the mid-to-high single digits.

Although below-the-line items did boost P&G's reported results, the company still posted a clean beat of five or six cents on better sales and margins.

SEE: Make Money With The Consumer Cyclical And Staple Indicator

Relative Performance Seems to Put P&G in the Middle
While better-than-expected performance is almost always a positive, it's also true that doing a little bit better means less if your peers are all doing a lot better. To that end, Procter & Gamble's performance seems to fit in the middle of the pack.

Unilever (NYSE:UL) saw nearly 8% organic growth, with nearly 5% growth in volume. Kimberly-Clark (NYSE:KMB) was also quite strong with 5% organic growth for its December quarter. On the other hand, Helen Of Troy (Nasdaq:HELE) saw a revenue decline in its personal care segment for the quarter that ended November 30. Johnson & Johnson (NYSE:JNJ) saw just 1% operational growth in its consumer segment, with categories like baby care (up 3%) and oral care (up 2%) showing comparable-to-lower performance relative to P&G.

All in all, however, I'm not too worried about where P&G sits in the industry. The company's portfolio tends to skew toward the higher end of the price range, which may explain why the company saw year-on-year share loss but improving sequential results. In other words, I think consumers are starting to feel a little better about their budgets/economic situations and tentatively going back up market - at least on selective items.

SEE: 5 Must-Have Metrics For Value Investors

The Bottom Line
The next couple of quarters will be important for Procter & Gamble on at least two levels. The Street will want more proof that the cost/margin improvements are real and sustainable. More importantly, the company also has several product launches coming up, and seeing good acceptance/sales of these products will definitely help sentiment and bulwark the near-term revenue outlook.

With P&G's modest outperformance, I'm modestly taking my numbers/estimates a little higher. Ultimately, however, not a lot changes. While I believe P&G can grow revenue at a mid-single-digit rate and grow cash flow at a high-single-digit rate, a fair value in the low $70s still doesn't suggest any real undervaluation in these shares today.

At the time of writing, Stephen D. Simpson did not own any shares in any company mentioned in this article.

Related Articles
  1. Stock Analysis

    Starbucks: Profiting One Cup at a Time (SBUX)

    Starbucks is everywhere. But is it a worthwhile business? Ask the shareholders who've made it one of the world's most successful companies.
  2. Stock Analysis

    How Medtronic Makes Money (MDT)

    Here's the story of an American medical device firm that covers almost every segment in medicine and recently moved to Ireland to pay less in taxes.
  3. Investing News

    Latest Labor Numbers: Good News for the Market?

    Some economic numbers are indicating that the labor market is outperforming the stock market. Should investors be bullish?
  4. Investing News

    Stocks with Big Dividend Yields: 'It's a Trap!'

    Should you seek high yielding-dividend stocks in the current investment environment?
  5. Investing News

    Should You Be Betting with Buffett Right Now?

    Following Warren Buffett's stock picks has historically been a good strategy. Is considering his biggest holdings in 2016 a good idea?
  6. Products and Investments

    Cash vs. Stocks: How to Decide Which is Best

    Is it better to keep your money in cash or is a down market a good time to buy stocks at a lower cost?
  7. Investing News

    Who Does Cheap Oil Benefit? See This Stock (DG)

    Cheap oil won't benefit most companies, but this retailer might buck that trend.
  8. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  9. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
  10. Investing News

    The UAE: An Emerging Economy for Investors

    The learning from UAE on how it succeeded with timely diversification when the BRICS nations and the neighboring oil-rich economies faced challenges.
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center